Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 223 publications
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: July 06, 2026
MRI-Guided Reduced-Volume RT for Early-Stage Glottic Cancer: A Prospective Phase 1 Trial with Quantification of Laryngeal Motion.
Journal: International journal of radiation oncology, biology, physics
Published: May 10, 2026
Immunotherapy for locally advanced head and neck squamous cell carcinoma: A review.
Journal: Cancer treatment reviews
Published: April 27, 2026
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 12, 2026
Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial.
Journal: Nature communications
Published: January 29, 2026
Lenalidomide for the Treatment of Chronic Oral Mucositis and Soft Tissue Necrosis After Radiation Therapy.
Journal: Practical radiation oncology
Published: January 12, 2026
Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 23, 2025
Integrating transcriptomic data and artificial intelligence to personalize curative treatments for head and neck cancer patients.
Journal: NPJ precision oncology
Published: October 22, 2025
Perioperative Pembrolizumab in Head and Neck Cancer. Reply.
Journal: The New England journal of medicine
Published: September 17, 2025
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 03, 2025
A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 14, 2025
Last Updated: 09/26/2026